Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
SYK
VRTX
Add up to 3 more stocks
SYK
Stryker Corporation
-1.17%
$278.57-3.29Delayed quote: Sep 15, 2026, 10:34 AM EDT
Market Cap
$106.79B
52W Range
$267.00 - $392.55
VRTX
Vertex Pharmaceuticals Incorporated
-1.23%
$513.10-6.41Delayed quote: Sep 15, 2026, 10:35 AM EDT
Market Cap
$130.23B
52W Range
$374.17 - $560.25
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 28.87 | 29.87 |
| Forward P/E | 18.56 | 27.37 |
| P/B Ratio | 4.45 | 6.43 |
| P/S Ratio | 4.13 | 10.32 |
| P/FCF Ratio | 22.71 | 34.31 |
| EV/EBITDA | 17.06 | 24.76 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 65.2% | 86.0% |
| Operating Margin | 22.0% | 38.6% |
| Net Margin | 14.4% | 34.9% |
| ROE | 15.6% | 21.8% |
| ROA | 7.8% | 16.1% |
| ROIC | 9.8% | 17.3% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.16 | 3.19 |
| Quick Ratio | 1.33 | 2.74 |
| Debt/Equity | 0.62 | 0.10 |
| Interest Coverage | 8.05 | 357.95 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 1.3% | N/A |
| Payout Ratio | 36.1% | N/A |
| Yrs of Dividend Growth | 16 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.